Google Übersetzer
Rigel Pharmaceuticals, Inc.
About
Rigel Pharmaceuticals, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
Yesterday
Rigel Reports First Quarter 2026 Financial Results
Apr 28 2026
Rigel Announces Conference Call and Webcast to Report First Quarter 2026 Financial Results
Mar 31 2026
Rigel Announces Publication of Final ARROW Clinical Trial Data on GAVRETO® (pralsetinib) in Patients with RET+ NSCLC in the Journal of Clinical Oncology
Mar 3 2026
Rigel Provides Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Feb 24 2026
Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Full Year 2025 Financial Results and Business Update
Recent Videos
Rigel Pharmaceuticals' 2025 Financial Surge! #RIGL #BiotechInvesting #FinancialForecast
Mar 31, 2026
Rigel Pharmaceuticals Inc. 2025 annual report
Mar 05, 2026
Rigel Pharmaceuticals Q4 2025 Earnings Call
Mar 04, 2026
RIGL Stock: 93% Margins & The Biggest Biotech Mispricing of 2026 (Forensic Analysis)
Mar 01, 2026